The impact of the disruption of DMS formation following IFN-β treatment still requires validation in infected cells, which would be most easily achieved if the responsible factor(s) was identified, because we could then evaluate the effect of this specific factor on replication organelles during infection. This evidence concerns the gene IFNB1 and infection.